Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
SAGE Therapeutics
company
About
SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.
- 501 - 1000
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $20M
- Industries
- Biotechnology,Medical,Therapeutics
- Founded date
- Jan 1, 2010
- Number Of Employee
- 501 - 1000
- Operating Status
- Active
SAGE Therapeutics is dedicated to the health and well being of patients with central nervous system (CNS) disorders. Their mission is to discover, develop and deliver novel medicines for many of today's most debilitating and disabling CNS disorders by leveraging compelling science, a robust clinical foundation, strong partnerships, and a world-class team of founders, advisors, investors, scientists and managers.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$58M
SAGE Therapeutics has raised a total of
$58M
in funding over 2 rounds. Their latest funding was raised on
Mar 13, 2014 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 13, 2014 | Series C | $38M | 1 | — | — | Detail |
| Oct 16, 2013 | Series B | $20M | 1 | — | — | Detail |
Investments
Number of Investments
Number of Lead Investments
4
1
SAGE Therapeutics has made 4 investments. Their most recent investment was on
Jun 6, 2021, when Snickerdoodle Labs raised $2.40M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jun 6, 2021
Snickerdoodle Labs
|
Seed | $2.40M | Blockchain | — |
|
Dec 17, 2019
Alchemy
|
Series A | $15M | Blockchain | — |
|
Sep 26, 2014
MoviePass
|
Series A | $2.20M | Apps | Yes |
|
Apr 1, 2014
Mavatar
|
Convertable Note | $2M | Affiliate Marketing | — |
Investors
Number of Lead Investors
Number of Investors
—
1
SAGE Therapeutics is funded by 1 investors.
ARCH Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
ARCH Venture Partners
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
